Abstract

While different definitions for the diagnosis of metabolic syndrome (MetS) have been proposed, their applicability brings confusion about which criteria should be used in clinical practice. This was an observational cross-sectional study conducted during October 2008. in 3 university hospital centers in the north, midst and south of the Serbia. 1715 patients were recruited from outpatient clinical practice and primary health care offices: 37% males and 63% females, aged 34-80 years. To evaluate the impact of different criteria in discriminating high risk population for coronary artery disease (CAD) we used NCEP-ATP III, AHA/NHLBI and IDF definitions. 21,7% (373) from the patients included in the study sustained CAD. The prevalence of MetS in the CAD group was 84,7%, 86,1% and 82,0%, respectively, compared with 58,3%, 60,6% and 61,2% in the control group (p<0.0001). ROC curves ploted by the probabilities for CAD calculated in the logistic models for each definition (adjusted for age, sex, smoking and educational status) indicated that NCEP-ATP III and NHLBI-AHA definitions had a better predictive accuracy compared with IDF (p=0,006 and p=0,016, respectively). When the waist girth is introduced in NCEP-ATP III and NHLBI-AHA definitions as obligatory, this distinction was lost. The NCEP-ATP III and AHA/NHLBI definition is more suitable for discrimination of MetS diagnosis, than the later proposed IDF definition in the subjects of the given population. Inclusion of waist circumference as obligatory criteria failed to show increase in predictive accuracy for CAD.

Highlights

  • After a brief loss of interest in metabolic syndrome (MetS), apon the criticism made on account of it’s diagnosis, the metabolic syndrome comes back into the spotlight, mainly because of its link with the global epidemics of cardiovascular diseases (CVD) and type 2 diabetes

  • By applying the different definitions of MetS according to NCEP ATP III, NHLBI/AHA and International Diabetes Federation (IDF), its prevalence in the coronary artery disease (CAD) group was 84,7%, 86,1% and 82,0%, respectively, compared with 58,3%, 60,6% and 61,2% in the control group

  • Univariate logistic regression models revealed that all 3 definitions of MetS were significantly associated with the presence of CAD (p

Read more

Summary

Introduction

After a brief loss of interest in metabolic syndrome (MetS), apon the criticism made on account of it’s diagnosis, the metabolic syndrome comes back into the spotlight, mainly because of its link with the global epidemics of cardiovascular diseases (CVD) and type 2 diabetes. This relationship was well established, but using different definitions proposed by several groups, brings confusion in clinical practice about which criteria should be used for the population of the given interest. The most widely used is the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) definition [1]. The major adjustment was to include persons reporting a history of current antihypertensive drug or lipid lowering medication use regardless of measured values

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call